Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177898 | SCV000229855 | uncertain significance | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085297 | SCV000562886 | benign | Long QT syndrome | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314638 | SCV000848230 | likely benign | Cardiovascular phenotype | 2016-11-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000177898 | SCV001859364 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000177898 | SCV002048844 | likely benign | not provided | 2021-02-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001729429 | SCV001978945 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000177898 | SCV001979318 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003955061 | SCV004770568 | likely benign | CACNA1C-related disorder | 2020-01-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |